Cleared Traditional

K133019 - FIBERION OPHTHALMIC ENDOLASER PROBE

K133019 is an FDA 510(k) clearance for FIBERION OPHTHALMIC ENDOLASER PROBE, manufactured by Emtron Elektronik VE Mekanik Sanayi VE Ticaret Lim. The device is a Class 2 Ophthalmic device with product code HQF cleared through the Traditional 510(k) pathway after a 512-day FDA review.

K133019 · Emtron Elektronik VE Mekanik Sanayi VE Ticaret Lim · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2015
Decision
512d
Days
Class 2
Risk

K133019 is an FDA 510(k) clearance for the FIBERION OPHTHALMIC ENDOLASER PROBE. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Emtron Elektronik VE Mekanik Sanayi VE Ticaret Lim (Istanbul, TR). The FDA issued a Cleared decision on February 20, 2015 after a review of 512 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Ophthalmic submissions.

View all Emtron Elektronik VE Mekanik Sanayi VE Ticaret Lim devices

FDA 510(k) Submission Details - K133019

510(k) Number K133019 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2013
Decision Date February 20, 2015
Days to Decision 512 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
402d slower than avg
Panel avg: 110d · This submission: 512d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQF Device Classification - Class 2, Special Controls

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQF Laser, Ophthalmic

All 100
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K133019.
YELLOW LASER PHOTOCOAGULATOR YLC-500
K170302 · Nidek Co., Ltd. · Jun 2017
R:GEN Laser System
K153769 · Lutronic Corporation · Oct 2016
Green Laser Photocoagulator GYC-500
K152603 · Nidek Co., Ltd. · May 2016
NIDEK MULTICOLOR LASER PHOTOCOAGULATOR SYSTEM MC-500 CONNECTED WITH THE ENDOPHOTOCOAGULATION DELIVERY UNIT
K133358 · Nidek Co., Ltd. · Aug 2014
OPTIMUS FUSION: SLT, YAG AND YAG/SLT
K140336 · Quantel Medical · Jun 2014
SCANNING LASERLINK
K130195 · Lumenis, Inc. · Nov 2013